Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018–2019

Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018–2019

Abstract Background The national policy for malaria treatment of the Democratic Republic of Congo recommends two first-line artemisinin-based combinations for the treatment of uncomplicated malaria: artesunate-amodiaquine and artemether-lumefantrine. This study investigated the presence of markers a...

Full description

Bibliographic Details
Main Authors: Doudou M. Yobi, Nadine K. Kayiba, Dieudonné M. Mvumbi, Raphael Boreux, Pius Z. Kabututu, Hippolyte N. T. Situakibanza, Solange E. Umesumbu, Patrick De Mol, Niko Speybroeck, Georges L. Mvumbi, Marie-Pierre Hayette
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Malaria Journal
Subjects:
Molecular
Markers
Anti-malarial
Resistance
Treatment
Failure
Online Access:https://doi.org/10.1186/s12936-021-03636-y

Internet

https://doi.org/10.1186/s12936-021-03636-y

Similar Items